All In Biotech

Drug Trial Radar · NCT02607865

Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes

Last checked: Nov 19, 2026Latest source record: Jul 20, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,864 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,864

Actual

Start

Feb 15, 2016

Primary completion

Feb 14, 2017

Study completion Mar 28, 2018

Sponsor

Lead sponsor
Novo Nordisk A/SNovo Nordisk (NVO)
Sponsor type
Industry
First posted
Nov 18, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This trial is conducted globally. The aim of the trial is to investigate efficacy and long-term safety of oral semaglutide versus sitagliptin in subjects with type 2 diabetes.

Conditions

  • Diabetes
  • Diabetes Mellitus, Type 2

Interventions

  • semaglutideDrug

    Oral administration once-daily

  • sitagliptinDrug

    Oral administration once-daily

  • placeboDrug

    Oral administration once-daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in HbA1c: Week 26Time frame: Week 0, week 26

Locations

242 sites in 15 countries. Site status is shown where the registry gives one.

  • Novo Nordisk Investigational Site

    Anniston, Alabama

  • Novo Nordisk Investigational Site

    Birmingham, Alabama

  • Novo Nordisk Investigational Site

    Tuscumbia, Alabama

  • Novo Nordisk Investigational Site

    Glendale, Arizona

  • Novo Nordisk Investigational Site

    Little Rock, Arkansas

  • Novo Nordisk Investigational Site

    Carmichael, California

  • Novo Nordisk Investigational Site

    Coronado, California

  • Novo Nordisk Investigational Site

    Encino, California

  • Novo Nordisk Investigational Site

    Fresno, California

  • Novo Nordisk Investigational Site

    Los Alamitos, California

  • Novo Nordisk Investigational Site

    Palm Springs, California

  • Novo Nordisk Investigational Site

    Poway, California

  • Novo Nordisk Investigational Site

    Walnut Creek, California

  • Novo Nordisk Investigational Site

    Denver, Colorado

  • Novo Nordisk Investigational Site

    Kissimmee, Florida

  • Novo Nordisk Investigational Site

    New Port Richey, Florida

  • Novo Nordisk Investigational Site

    Palm Harbor, Florida

  • Novo Nordisk Investigational Site

    Plantation, Florida

  • Novo Nordisk Investigational Site

    Port Charlotte, Florida

  • Novo Nordisk Investigational Site

    Spring Hill, Florida

  • Novo Nordisk Investigational Site

    Tampa, Florida

  • Novo Nordisk Investigational Site

    Marietta, Georgia

  • Novo Nordisk Investigational Site

    Perry, Georgia

  • Novo Nordisk Investigational Site

    Honolulu, Hawaii

  • Novo Nordisk Investigational Site

    Meridian, Idaho

  • Novo Nordisk Investigational Site

    Gurnee, Illinois

  • Novo Nordisk Investigational Site

    Peoria, Illinois

  • Novo Nordisk Investigational Site

    Peoria, Illinois

  • Novo Nordisk Investigational Site

    Avon, Indiana

  • Novo Nordisk Investigational Site

    Park City, Kansas

  • Novo Nordisk Investigational Site

    Lexington, Kentucky

  • Novo Nordisk Investigational Site

    Louisville, Kentucky

  • Novo Nordisk Investigational Site

    Paducah, Kentucky

  • Novo Nordisk Investigational Site

    Paducah, Kentucky

  • Novo Nordisk Investigational Site

    Metairie, Louisiana

  • Novo Nordisk Investigational Site

    Natchitoches, Louisiana

  • Novo Nordisk Investigational Site

    Shreveport, Louisiana

  • Novo Nordisk Investigational Site

    Rockville, Maryland

  • Novo Nordisk Investigational Site

    Waltham, Massachusetts

  • Novo Nordisk Investigational Site

    Flint, Michigan

Showing 40 of 242 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.